Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation with remimazolam vs propofol for electrical cardioversion in atrial fibrillation
ChiCTR2500095498Phase 4Not yet recruiting
- Sponsor
- Department of Cardiovasology Changhai Hospital Naval Medical University Shanghai
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Atrial fibrillation (AFib) (2 arms), sponsored by Department of Cardiovasology Changhai Hospital Naval Medical University Shanghai. Primary endpoint: sedation recovery time. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2500095498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095498.